|
Group Post |
Russia's virus cases exceed 1 million; 4th highest globally |
mike kraft |
|
Group Post |
AstraZeneca seeks U.S. FDA authorisation of drug to prevent COVID-19 |
mike kraft |
|
Group Post |
U.S. CDC warns of severe illnesses from monkeypox; Ohio reports death of a monkeypox patient |
mike kraft |
|
Group Post |
WHO is waiting for full data on Merck antiviral pill |
mike kraft |
|
Group Post |
FDA will let some adults get a second boost of the bivalent COVID-19 shot--sources |
mike kraft |
|
Group Post |
U.S. Covid winters are making long hospital waits the new normal |
mike kraft |
|
Group Post |
BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion doses |
mike kraft |
|
Group Post |
Taiwan, once a covid success story, faces outbreak and vaccine shortage |
mike kraft |
|
Group Post |
U.S. needs 193 million Covid-19 tests per month to reopen schools and keep up with pandemic, new report says |
mike kraft |
|
Group Post |
Vaccine trials on Sudan Ebola strain to start in weeks - WHO chief |
mike kraft |
|
Group Post |
CDC advisers vote to recommend booster shots of Johnson & Johnson and Moderna Covid-19 vaccines |
mike kraft |
|
Group Post |
Two drug combination shows protection against severe COVID-19 |
mike kraft |
|
Group Post |
Mpox: Almost gone in the US, leaving lessons and mysteries in its wake |
mike kraft |
|
Group Post |
Explainer: Updated COVID-19 vaccines are expected in the U.S. next month, considerations in getting one |
mike kraft |
|
Group Post |
Uganda's Ebola outbreak worsens, country sets up additional treatment center |
mike kraft |
|
Group Post |
Travel: Russia, Belgium moves to CDC's highest risk travel category |
mike kraft |
|
Group Post |
Opinion: The Covid-19 emergency is ending. It’s time for the patient to leave the hospital |
mike kraft |
|
Group Post |
Long-COVID: patients report job, money issues; and the effecs on the brain |
mike kraft |
|
Group Post |
New anti-malaria vaccine shows promising results |
mike kraft |
|
Group Post |
Opinion: OPINION After COVID and monkeypox, it's time to rethink how U.S. responds to infectious diseases |
mike kraft |
|
Group Post |
Is Covid’s winter surge already here? Experts warn the pandemic isn’t over |
mike kraft |
|
Group Post |
Confidence in science fell in 2022 amid political divides--poll |
mike kraft |
|
Group Post |
Discussion of the most Common Long COVID Symptoms |
mike kraft |
|
Group Post |
EU health regulator says COVID pandemic not over |
mike kraft |
|
Group Post |
U.S. has stockpiled millions of doses of two smallpox vaccines, also effective against monkeypox. But the outbreaks so far are clustered in other countries. |
mike kraft |
Recent Comments